Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

Published in: Tropical diseases, travel medicine and vaccines (2021)

The overall results of the study suggest that the final multi-epitope chimeric construct is a potential candidate for an efficient protective vaccine against SARS-CoV-2.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
monoclonal antibody
cell therapy
risk assessment